Even if biotech companies like TG Therapeutics and Clovis Oncology don’t get bought out, they’re still attractive on a standalone basis.

Here are the biotech stocks to buy that we think will see magnified growth over the coming year. Real Money writer Bret Jensen reveals his top picks.

Immunomedics, Scientific Games, Axsome Therapeutics, Seattle Genetics and Vaxart are some of the top gainers for Monday.

Axsome's treatment 'rapidly improved agitation symptoms,' the company says. About 70% of Alzheimer's patients experience agitation.

"High energy prices are largely a result of underinvestment by many in the energy industry over the last several years and especially during the pandemic," Exxon said.

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

A popular entertainer is ready to reschedule a series of performances that were cancelled at the Colosseum at Caesars Palace on the Las Vegas Strip.